Adage Capital Partners Gp, L.L.C. Aptinyx Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$3.99 - $19.33 $1.46 Million - $7.06 Million	-365,018 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$16.15 - $28.93 $1.61 Million - $2.89 Million	-100,000 Reduced 21.5%	365,018 $6.04 Million
Q3 2018 Nov 14, 2018	SELL	$20.21 - $31.85 $2.02 Million - $3.19 Million	-100,000 Reduced 17.7%	465,018 $13.5 Million
Q2 2018 Aug 14, 2018	BUY	$19.83 - $24.17 $11.2 Million - $13.7 Million	565,018 New	565,018 $13.7 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.